Takeda India, part of the Takeda Pharmaceutical Company Limited, a global biopharmaceutical company, has announced a donation of ₹ 1.2 Crores to the PM Cares Fund to support India’s fight against COVID-19.
The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease. Bringing innovative therapies to patients, supporting them through their disease journeys, and playing its part in helping to strengthen healthcare systems is fundamental to Takeda’s operating model, especially in Emerging Markets like India.
Koki Sato, General Manager, Takeda India, commented: “Takeda remains committed to standing together and supporting our communities in India during this unprecedented health crisis. Together with key authorities and partners we look to addressing some of the world’s most pressing and unmet health challenges, including COVID-19.”
Takeda India has worked with NGO partners in the past to support patients and strengthen front-line caregivers through training programs, as part of their corporate social responsibility (CSR) mission. Globally, Takeda works towards preventing disease, training health workers, strengthening supply chains, and improving access to quality diagnosis and treatment. The company actively partners with world-class organizations and NGOs with proven track records to address global health problems in innovative and enduring ways.
Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content.
